CLPBY
Price
$8.19
Change
-$0.64 (-7.25%)
Updated
Feb 3 closing price
Capitalization
19.1B
2 days until earnings call
Intraday BUY SELL Signals
ESLOY
Price
$151.33
Change
-$8.89 (-5.55%)
Updated
Feb 3 closing price
Capitalization
140.28B
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLPBY vs ESLOY

Header iconCLPBY vs ESLOY Comparison
Open Charts CLPBY vs ESLOYBanner chart's image
Coloplast AS
Price$8.19
Change-$0.64 (-7.25%)
Volume$311.26K
Capitalization19.1B
EssilorLuxottica
Price$151.33
Change-$8.89 (-5.55%)
Volume$56.76K
Capitalization140.28B
CLPBY vs ESLOY Comparison Chart in %
CLPBY
Daily Signal:
Gain/Loss:
ESLOY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLPBY vs. ESLOY commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBY is a Hold and ESLOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (CLPBY: $8.19 vs. ESLOY: $151.33)
Brand notoriety: CLPBY and ESLOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CLPBY: 74% vs. ESLOY: 84%
Market capitalization -- CLPBY: $19.1B vs. ESLOY: $140.28B
CLPBY [@Pharmaceuticals: Other] is valued at $19.1B. ESLOY’s [@Pharmaceuticals: Other] market capitalization is $140.28B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.76B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBY’s FA Score shows that 1 FA rating(s) are green whileESLOY’s FA Score has 2 green FA rating(s).

  • CLPBY’s FA Score: 1 green, 4 red.
  • ESLOY’s FA Score: 2 green, 3 red.
According to our system of comparison, both CLPBY and ESLOY are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBY’s TA Score shows that 2 TA indicator(s) are bullish while ESLOY’s TA Score has 4 bullish TA indicator(s).

  • CLPBY’s TA Score: 2 bullish, 8 bearish.
  • ESLOY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ESLOY is a better buy in the short-term than CLPBY.

Price Growth

CLPBY (@Pharmaceuticals: Other) experienced а -4.43% price change this week, while ESLOY (@Pharmaceuticals: Other) price change was -2.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.44%. For the same industry, the average monthly price growth was -0.46%, and the average quarterly price growth was +23.04%.

Reported Earning Dates

CLPBY is expected to report earnings on Feb 06, 2026.

ESLOY is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-1.44% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($140B) has a higher market cap than CLPBY($19.1B). ESLOY has higher P/E ratio than CLPBY: ESLOY (49.81) vs CLPBY (32.14). CLPBY YTD gains are higher at: -3.647 vs. ESLOY (-4.475). CLPBY has higher annual earnings (EBITDA): 8.36B vs. ESLOY (6.71B). CLPBY (27.9B) and ESLOY (27.2B) have equivalent revenues.
CLPBYESLOYCLPBY / ESLOY
Capitalization19.1B140B14%
EBITDA8.36B6.71B125%
Gain YTD-3.647-4.47581%
P/E Ratio32.1449.8165%
Revenue27.9B27.2B103%
Total CashN/A3.16B-
Total DebtN/A14B-
FUNDAMENTALS RATINGS
CLPBY vs ESLOY: Fundamental Ratings
CLPBY
ESLOY
OUTLOOK RATING
1..100
7058
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
10023
SMR RATING
1..100
4395
PRICE GROWTH RATING
1..100
6261
P/E GROWTH RATING
1..100
6355
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBY's Valuation (6) in the null industry is in the same range as ESLOY (33). This means that CLPBY’s stock grew similarly to ESLOY’s over the last 12 months.

ESLOY's Profit vs Risk Rating (23) in the null industry is significantly better than the same rating for CLPBY (100). This means that ESLOY’s stock grew significantly faster than CLPBY’s over the last 12 months.

CLPBY's SMR Rating (43) in the null industry is somewhat better than the same rating for ESLOY (95). This means that CLPBY’s stock grew somewhat faster than ESLOY’s over the last 12 months.

ESLOY's Price Growth Rating (61) in the null industry is in the same range as CLPBY (62). This means that ESLOY’s stock grew similarly to CLPBY’s over the last 12 months.

ESLOY's P/E Growth Rating (55) in the null industry is in the same range as CLPBY (63). This means that ESLOY’s stock grew similarly to CLPBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBYESLOY
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
44%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 9 days ago
61%
Bullish Trend 22 days ago
57%
Declines
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
27%
View a ticker or compare two or three
Interact to see
Advertisement
CLPBY
Daily Signal:
Gain/Loss:
ESLOY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASTL4.500.27
+6.38%
Algoma Steel Group
FHN25.720.90
+3.63%
First Horizon Corp
AAPG23.330.16
+0.69%
Ascentage Pharma Group
HYFT1.57-0.05
-3.09%
MindWalk Holdings Corp.
ENSC0.61-0.10
-14.10%
Ensysce Biosciences

CLPBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with CLPBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then CLPBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
-2.79%
CLPBF - CLPBY
38%
Loosely correlated
N/A
SAUHY - CLPBY
34%
Loosely correlated
-2.68%
SMMNY - CLPBY
33%
Poorly correlated
-1.31%
SONVY - CLPBY
32%
Poorly correlated
-2.17%
ESLOY - CLPBY
32%
Poorly correlated
-0.59%
More

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
-0.59%
ESLOF - ESLOY
58%
Loosely correlated
-2.43%
QGEN - ESLOY
43%
Loosely correlated
-0.56%
ALC - ESLOY
38%
Loosely correlated
-2.58%
SMMNY - ESLOY
38%
Loosely correlated
-1.31%
CRL - ESLOY
35%
Loosely correlated
-5.54%
More